Kelly L Walton
Kelly was awarded her PhD in 2008 at Swinburne University (Hawthorn, Australia). Her PhD thesis examined the use of baculoviruses as gene delivery agents for mammalian cells. Since 2008, Kelly has been working as a postdoc in the Growth Factor Signalling Laboratory at MIMR-PHI Institute (Clayton, Australia). Kelly’s research focuses on the family of Transforming Growth Factor -beta (TGF-beta) proteins, which regulate cell growth, proliferation and differentiation. Kelly’s mission is to design specific and potent protein therapeutics for human diseases associated with altered TGF-beta signalling. Kelly was recently awarded the Endocrine Society of Australia’s Postdoctoral Fellowship for 2013.
Abstracts this author is presenting: